Three keys to understanding the pharmaceutical market: sustainability, competition and pricing

The percentage of GDP that the state spends on pharmaceuticals has not increased in the last 20 years. Between 2018 and 2023, the increase in the average price of medicines has been 6.5 times lower than inflation in pharmacies and 2.5 times lower in hospitals. 86% of the units of medicines sold in pharmacies (branded […]

Farmaindustria highlights the ‘paradigm shift’ of AI in biomedical research

The head of Innovation and director of Innovation at Farmaindustria, Miguel González, highlighted how Artificial Intelligence (AI) has brought about a paradigm shift and a revolution in biomedical research. González made these statements during the dialogue ‘Contribution of AI to social projects’, organised by Servimedia. González was joined by Jesús Herrero, General Director of Red.es; […]

The impact of the innovative pharmaceutical industry in Europe: 46.2 billion euros of R&D investment and the creation of more than 2.3 million jobs

A report by PwC for the European Federation of the Pharmaceutical Industry shows that the pharmaceutical industry contributes an economic value to the EU of 311,000 million euros and is three times more productive than the European economy as a whole. Of this contribution, more than 24,000 million corresponds to the pharmaceutical industry in Spain, […]

Public investment in medicines remains stable in terms of GDP, which reinforces the idea of long-term financial sustainability.

Farmaindustria presents ‘The pharmaceutical industry and its context in Spain 2024’, the first report that brings together in a single volume all the figures of the health sector from various public databases for quick and easy consultation. The work includes the contribution of the pharmaceutical industry in Spain in the health, economic and social spheres. […]

Advances the strategy to promote clinical trials in primary care centres, which will bring new treatment opportunities to patients in Spain.

One year after the presentation of the ‘Guide of good practice recommendations for the promotion of clinical research in primary care’, promoted by Farmaindustria, successful initiatives have already been identified in different autonomous communities. This work has become a ‘country project’, which aims to transfer Spain’s leadership in clinical research in the hospital setting to […]

‘Good implementation of pharmacogenomic markers will optimise the use of medicines and improve health outcomes’.

Arantxa Sancho, director of the Department of Medical-Scientific Affairs at Farmaindustria, participates in the informative seminar on pharmacogenomic biomarkers organised by the Aemps. Farmaindustria.es On 29 July, the Spanish Agency for Medicines and Health Products (Aemps) launched the first European and Spanish-language database of pharmacogenomic biomarkers in medicines datasheets. This initiative is a compilation of […]

Farmaindustria connects eight research projects from Spanish universities and small companies with 15 representatives from pharmaceutical companies

The Farma-Biotech programme facilitates the efficient exchange of information and personal knowledge between research groups, small spin-off companies and the pharmaceutical industry. Since its inception in 2011, the Farmaindustria-driven project has analysed more than 900 innovative proposals for new drugs in early stages of development. Framaindustria.es Eight heads of research projects on potential new drugs […]

Open doors for research

Farmaindustria is leading a project to bring clinical trials to primary care to help decentralise this strategy. laopiniondezamora.es ‘Transforming primary care through clinical trials’ was the title of the meeting organised by the National Business Association of the Pharmaceutical Industry, Farmaindustria, together with LA OPINIÓN-EL CORREO DE ZAMORA. The event was attended by Amelia Martín […]

New report on clinical trials places Spain as a leader and success story in Europe

Assessing Europe’s clinical trial ecosystem, produced by Iqvia for Efpia and Vaccines Europe, shows a 22-12% drop in the share of studies on the continent over the last decade. This means that 60,000 European patients have lost the opportunity to access new experimental phase drugs between 2018 and 2023. Spain is working to strengthen its […]

Fina Lladós, new president of Farmaindustria: ‘I will work to generate confidence and make the industry strategic in the economic and social development of Spain’.

The Extraordinary General Assembly on Thursday unanimously elected the CEO of Amgen Iberia to lead the Association for the next two years. Source: Farmaindustria.es Fina Lladós will chair Farmaindustria for the next two years. The CEO of the biotech company Amgen was unanimously elected this Thursday at the Extraordinary General Assembly of Farmaindustria to succeed […]